Browsing by Contributors Gong, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 6 of 6
PreviewIssue DateTitleContributor(s)
19-Feb-2016BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerBreast Cancer Now; Breast Cancer Campaign and Breakthrough Breast Cancer; Imperial College Trust; Lam, EW; Gong, C; Yao, S; Gomes, AR
27-Jan-2015FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.Gong, C; Fujino, K; Monteiro, LJ; Gomes, AR; Drost, R; Davidson-Smith, H; Takeda, S; Khoo, US; Jonkers, J; Sproul, D; Lam, EW
27-Jan-2015FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.Gong, C; Fujino, K; Monteiro, LJ; Gomes, AR; Drost, R; Davidson-Smith, H; Takeda, S; Khoo, US; Jonkers, J; Sproul, D; Lam, EW
22-Aug-2016FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistanceKhongkow, P; Karunarathna, U; Khongkow, M; Gong, C; Gomes, AR; Yague, E; Monteiro, LJ; Kongsema, M; Zona, S; Man, EPS; Tsang, JW-H; Coombes, RC; Wu, K-J; Khoo, U-S; Medema, RH; Freire, R; Lam, EW-F
4-May-2016OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistanceBreast Cancer Now; Breast Cancer Campaign and Breakthrough Breast Cancer; Karunarathna, U; Kongsema, M; Zona, S; Gong, C; Cabrera, E; Gomes, AR; Man, EPS; Khongkow, P; Tsang, JW-H; Khoo, U-S; Medema, RH; Freire, R; Lam, EW-F
21-May-2015Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.Breast Cancer Now; Breast Cancer Campaign and Breakthrough Breast Cancer; Khongkow, P; Gomes, AR; Gong, C; Man, EP; Tsang, JW; Zhao, F; Monteiro, LJ; Coombes, RC; Medema, RH; Khoo, US; Lam, EW